Biosciences coverage.

Caribou Biosciences, Inc. (CRBU) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Caribou Biosciences, Inc. (CRBU) Jefferies Global Healthcare Conference 2026 June 4, 2026 2:35 PM EDTCompany ParticipantsRachel Haurwitz - Co-Founder, CEO,...…

Cantor Fitzgerald reiterates Ideaya Biosciences stock rating

Form 13G Xenetic Biosciences For: 29 May

Form S-1/A Cellectar Biosciences Inc For: 29 May

Form 144 NEUROCRINE BIOSCIENCES INC For: 27 May

Precision BioSciences, Inc. (DTIL) Discusses Updates on PBG and HBV Program and ELIMINATE-B Trial Results - Slideshow

2026-05-27. The following slide deck was published by Precision BioSciences, Inc.…

Artelo Biosciences stock tumbles on $6.5M share offering

Nielsen BioSciences Announces Positive Phase 3 Trial Results of CANDIN for the Treatment and Clearance of Common Warts - Morningstar

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…

Acurex Biosciences Awarded ASAP Grant to Advance Breakthrough Approach to Parkinson’s Disease - Morningstar

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…

Junshi Biosciences completes phase III lung cancer study

Pacific Biosciences: Pressure Is Rising

Pacific Biosciences of California has lost over 95% of its value in five years, underperforming the S&P 500 despite recent volatility. See why PACB stock is a Sell.…

H.C. Wainwright reiterates Harmony Biosciences stock rating at buy

Assembly Biosciences prices $100 million stock offering at $26.50

STAT+: Longevity startup Retro Biosciences says latest fundraising values it at $1.8 billion

Retro Biosciences, the longevity startup backed by OpenAI CEO Sam Altman, has raised more money at a $1.8 billion valuation, it announced Friday.…

Neurocrine Biosciences Hits New Highs On Earnings Surge

Biotech stock Neurocrine Biosciences is hovering below its all-time high after first-quarter earnings surged more than 2,000%.…

Where Will Solid Biosciences Inc (SLDB) Stock Be in the Next 12 Months?

Solid Biosciences Inc (NASDAQ:SLDB) is one of the best gene therapy stocks to buy in 2026. The stock has been a big win for investors, having gained roughly 75% over the past six m…

Chicks hatched from artificial eggs in scientific first — it could a game-changer for bringing extinct animals back to life

Could this bring species back from egg-stinction?…

Pacira BioSciences: Exparel Still Supports My Original Bull Case

Explore PCRX stock catalysts into 2026, Exparel dependency risks, and pipeline readouts.…

First They Brought Back Dire Wolves. Next Up? Artificial Wombs

Science start-up Colossal is on a mission to make animals “productionized” — getting rid of the need for eggs or wombs. And it’s already worth billions…

Gustave Roussy and One Biosciences Partner to Bring Single Cell to Clinical Practice for Precision Oncology - Morningstar

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…

Form PRE 14A CELLECTAR BIOSCIENCES For: 18 May

Earnings call transcript: Coherus BioSciences Q1 2026 revenue miss prompts cautious outlook

Tyra Biosciences Stock Has Soared 280% in a Year. One Fund Just Disclosed Buying More Shares

Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors.

Forte Biosciences: Targeting Celiac Disease

Forte Biosciences (FBRX) surged on 2026 FB102 data hopes. See here for Phase 1b celiac results, competition risks, valuation vs. cash, and outlook.…